Scarica l'app Stockscreener
2.43
8.97%
0.20
Pre-mercato:
2.44
0.010
+0.41%
Precedente Chiudi:
$2.23
Aprire:
$2.36
Volume 24 ore:
348.91K
Relative Volume:
0.85
Capitalizzazione di mercato:
$47.35M
Reddito:
-
Utile/perdita netta:
$-30.26M
Rapporto P/E:
-1.1912
EPS:
-2.04
Flusso di cassa netto:
$-24.69M
1 W Prestazione:
-6.90%
1M Prestazione:
-15.92%
6M Prestazione:
+39.66%
1 anno Prestazione:
-74.87%
Intervallo 1D:
$2.30
$2.505
Intervallo di 1 settimana:
$2.21
$2.60
Portata 52W:
$1.11
$10.54
Annovis Bio Inc Stock (ANVS) Company Profile
Nome
Annovis Bio Inc
Settore
Industria
Telefono
484-875-3192
Indirizzo
101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA
Confronta ANVS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANVS
Annovis Bio Inc
|
2.43 | 52.42M | 0 | -30.26M | -24.69M | -2.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.18 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
587.65 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.20 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
708.09 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.91 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Annovis Bio Inc Stock (ANVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-10 | Downgrade | D. Boral Capital | Buy → Hold |
| 2024-10-25 | Aggiornamento | Maxim Group | Hold → Buy |
| 2023-12-29 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-07 | Reiterato | Maxim Group | Buy |
Annovis Bio Inc Borsa (ANVS) Ultime notizie
How to build a custom watchlist for Annovis Bio Inc.Earnings Risk Summary & Real-Time Price Movement Reports - Newser
Live Scanner Shows Breakout on Annovis Bio Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
What earnings revisions data tells us about Annovis Bio Inc.Bear Alert & Weekly Top Gainers Alerts - Newser
Regression analysis insights on Annovis Bio Inc. performanceEarnings Trend Report & Stepwise Trade Execution Plans - Newser
Analyzing drawdowns of Annovis Bio Inc. with statistical tools2025 Volume Leaders & Expert Curated Trade Ideas - Newser
How institutional ownership impacts Annovis Bio Inc. stockWeekly Trade Report & Low Risk Investment Opportunities - Newser
Price action breakdown for Annovis Bio Inc.July 2025 Trade Ideas & Safe Entry Point Alerts - Newser
Real time breakdown of Annovis Bio Inc. stock performanceIPO Watch & Risk Controlled Swing Alerts - Newser
Can Annovis Bio Inc. hit a new high this monthMarket Trend Review & Real-Time Volume Analysis Alerts - Newser
How to integrate Annovis Bio Inc. into portfolio analysis toolsEarnings Summary Report & Weekly Stock Performance Updates - Newser
Published on: 2025-08-26 01:42:56 - Newser
Will Annovis Bio Inc. see short term momentumPortfolio Risk Summary & High Win Rate Trade Tips - Newser
Can a trend reversal in Annovis Bio Inc. lead to recoveryJuly 2025 Intraday Action & Daily Volume Surge Signals - Newser
Live Scanner Shows Breakout on Annovis Bio Inc.Quarterly Market Summary & Safe Capital Growth Stock Tips - 더경남뉴스
RSI + MACD Show Convergence for Annovis Bio Inc.Jobs Report & Safe Entry Trade Reports - newsyoung.net
Will Annovis Bio Inc. outperform tech stocksJuly 2025 Short Interest & Weekly High Return Stock Opportunities - theviewers.co.kr
Can Annovis Bio Inc. disrupt its industryWeekly Investment Recap & Daily Risk Controlled Trade Plans - theviewers.co.kr
Is Annovis Bio Inc.’s ROIC above industry averageMarket Trend Summary & Consistent Profit Trading Strategies - theviewers.co.kr
Is Annovis Bio Inc. impacted by rising ratesAnalyst Downgrade & Growth Oriented Trade Recommendations - theviewers.co.kr
What moving averages say about Annovis Bio Inc.2025 Analyst Calls & AI Driven Price Predictions - Newser
Using data tools to time your Annovis Bio Inc. exitWeekly Investment Recap & Technical Pattern Based Signals - Newser
Will Annovis Bio Inc. stock split in the near futureWall Street Watch & Weekly Top Gainers Trade List - Newser
What MACD signals say about Annovis Bio Inc.2025 Technical Overview & Fast Momentum Entry Tips - Newser
Will Annovis Bio Inc. continue its uptrendWeekly Stock Report & Daily Profit Maximizing Tips - Newser
Strategies to average down on Annovis Bio Inc.July 2025 Summary & Safe Capital Preservation Plans - Newser
Annovis Bio Reports Q2 2025 Progress and Financials - TipRanks
Annovis Bio Secures Full Patent Protection for New Crystal Form of Alzheimer’s Drug Buntanetap - MSN
Michelle Chen named CEO of gene therapy play Form Bio - BioCentury
Quant Strategy Flags Annovis Bio Inc. for Entry2025 Earnings Impact & Technical Confirmation Alerts - newsyoung.net
Annovis Bio Advances Alzheimer’s Phase 3 Trial, Strengthens IP Portfolio - MSN
Historical volatility pattern of Annovis Bio Inc. visualizedEarnings Trend Report & Verified Technical Trade Signals - Newser
What makes Annovis Bio Inc. stock price move sharplyGap Up & Safe Capital Investment Plans - thegnnews.com
Short interest data insights for Annovis Bio Inc.July 2025 Recap & High Conviction Buy Zone Picks - Newser
Annovis Bio appoints CEO as acting CFO following executive resignation By Investing.com - Investing.com India
Annovis Bio appoints CEO as acting CFO following executive resignation - Investing.com
Annovis Bio Inc. Rebound Backed by Sentiment ShiftJuly 2025 Catalysts & Reliable Intraday Trade Plans - beatles.ru
Annovis Bio’s Promising Alzheimer’s Drug Trial: What Investors Need to Know - TipRanks
Annovis Provides Corporate Updates and Reports Second Quarter 2025 Financial Results - GlobeNewswire
Annovis Bio Q2 Earnings: EPS Loss Narrows, No Revenue Reported, Cash and Cash Equivalents Rise to $17.1 Million - AInvest
ANNOVIS BIO -REDH Earnings Results: $ANVS Reports Quarterly Earnings - Quiver Quantitative
Annovis Reports Q2 2025 Financial Results, Drives Enrollment for Phase 3 AD Trial - AInvest
Annovis Bio, Inc. SEC 10-Q Report - TradingView
Annovis Advances Alzheimer's Phase 3 Trial With 76 Sites, Reports Stronger Cash Position - Stock Titan
Annovis Bio Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView
Annovis Bio ANVS Q2 2025 Earnings Preview Upside Potential on Strategic Innovations - AInvest
How sensitive is Annovis Bio Inc. to inflationTechnical Confluence Stock Ideas - mustnews.co.kr
Is now a turning point for Annovis Bio Inc.Trading Watchlist with Real Time Filters - Newser
RSI Reset May Fuel Rebound in Annovis Bio Inc.Weekly Stock Watch With Growth Focus Expanded - beatles.ru
Why Annovis Bio Inc. is moving todayJuly 2025 Highlights & Real-Time Volume Analysis - Newser
Annovis Bio completes full patent transfer to crystal buntanetap - TipRanks
Annovis Completes Full Patent Transfer to Crystal Buntanetap - Santé log
Annovis Bio Inc Azioni (ANVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.95%
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):